Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Baricitinib may effectively treat oral lichen planus.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Ocrelizumab may cause total body hair loss in some patients.

Dupilumab can help regrow hair in alopecia areata but stopping it may cause hair loss again.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

Omalizumab may cause hair loss.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Ocrelizumab may cause pancreatitis in some patients.

Dupilumab may help treat alopecia areata, but more research is needed.

Baricitinib is effective as a treatment for severe hair loss.

A woman with a rare autoimmune disorder had a blister on her eye and unique immune reaction, which was effectively treated with medication.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.